Opendata, web and dolomites


ICT platform to reduce mortality rates for Transcatheter Aortic Valve Implantation (TAVI) by pre-operative risk management

Total Cost €


EC-Contrib. €






 TAVIguide project word cloud

Explore the words cloud of the TAVIguide project. It provides you a very rough idea of what is the project "TAVIguide" about.

surgeons    mitigate    4x    positive    tavi    offers    2021    plus    12    provides    procedure    device    share    ageing    patient    found    operative    manufacturers    3d    grow    enabled    society    business    tackle    approval    flow    therapy    preparation    elaborated    groups    model    optimize    thereby    centres    prepare    our    prospective    plan    entry    simulation    selling    huge    reducing    vii    mortality    license    implantation    innovative    feasibility    fda    mitral    healthcare    fee    patients    4b    heart    valve    health    fast    lt    offerings    market    trade    personalized    sustainable    2014    groundbreaking    taviguide    global    physicians    digital    validation    blood    distinctly    commercialization    additional    risk    platform    25    pillar    population    service    thanks    2025    beneficial    disruptive    quality    proposition    7b    stakeholders       give    disease    medical    complications    correctly    rates       benefits    software    solution    marketing    accurate    analysed    aortic    care    ict    competitive    verified    economic    revenue    size   

Project "TAVIguide" data sheet

The following table provides information about the project.


Organization address
city: GENT
postcode: 9052
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FEOPS NV BE (GENT) coordinator 50˙000.00


 Project objective

Our market disruptive TAVIguide™ ICT solution (a Software-as-a-Service platform) will be distinctly beneficial for the global healthcare system with a positive impact on two main groups: a favourable economic impact for medical centres and physicians and an improved quality of care and experience for patients. Our ICT platform addresses an innovative digital health ICT concept and service and will help to tackle the society's challenge of growing needs for sustainable and personalized healthcare (ICT Pillar VII “ICT-enabled benefits for EU society”). It provides surgeons with a groundbreaking ICT solution thanks to beyond State-of-the-Art patient-specific 3D heart modelling and blood flow simulation for pre-operative analysis and preparation of aortic valve implantation. These unique features, not found in competitive offerings, allow to correctly assess and mitigate the complications risk, thereby reducing mortality rates across all TAVI patients from up to 25% after 1 year to <5%. Our TAVIguide™ platform offers a huge potential to device manufacturers who can use the accurate modelling and simulation features to further optimize their TAVI devices and prepare the way for patient-specific valve design. Our business concept is based on a software license revenue model plus fee per case. FDA approval and validation in a prospective patient study during Phase 2 will give us a unique selling proposition for different TAVI stakeholders. Commercialization of TAVIguide™ is planned on a global scale (EU and US). Due to the growing medical importance of the TAVI procedure and an ageing population, the target TAVI market is expected to grow from 1.4B€ (2014) to 4.7B€ (2025). We aim for a 12.6% share by 2021. An additional market entry for mitral valve disease therapy, 4x the TAVI market size, will be analysed. The elaborated business plan and verified technical and marketing feasibility for additional medical applications will prepare our solution for fast market uptake.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TAVIGUIDE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TAVIGUIDE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More